SARS-CoV-IN-2 is primarily used in research and development for studying potential treatments against SARS-CoV-2, the virus responsible for COVID-19. It serves as an inhibitor, targeting specific viral components to disrupt the virus's ability to replicate and infect host cells. This makes it a valuable tool in antiviral drug discovery, particularly in screening and evaluating compounds that could lead to effective therapeutics. Additionally, it aids in understanding the mechanisms of viral infection and resistance, contributing to the broader scientific effort to combat coronavirus-related diseases. Its application is largely confined to laboratory settings, where it helps advance knowledge and strategies for managing and preventing future outbreaks.